Camtek Ltd (CAMT) 2.99 $CAMT Looking for a Top Momentum

New Post Public Reply Private Reply Replies (0) Message Board

Sep 23, 2016 at 7:08 AM

Camtek Ltd (CAMT) 2.99 $CAMT

Looking for a Top Momentum Stock? 3 Reasons Why Camtek (CAMT) is a Great Choice
Zacks Equity Research - Zacks Investment Research - Tue Sep 20, 7:47AM CDT
Camtek is an impressive stock as it has a strong Momentum Score, favorable Zacks Rank and is also seeing positive estimate revisions.
CAMT: 2.99 (+0.14)

Fitbit (FIT) Expands in Ireland Despite Apple Tax Fiasco
Zacks Equity Research - Zacks Investment Research - Mon Sep 05, 8:17AM CDT
Fitbit Inc. (FIT) remains firm on its expansion plans in Europe and has set up its regional headquarters in Dublin, Ireland despite the Apple tax fiasco.
FIT: 16.76 (+0.49), CAMT: 2.99 (+0.14), AAPL: 114.62 (+1.07), NVMI: 12.13 (+0.06)

Fitbit's (FIT) New Fitness Wearables for the Holiday Season
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 10:20AM CDT
Shares of Fitbit Inc. (FIT), a major player in the global wearable fitness segment has launched two new fitness products ahead of the holidays.
FIT: 16.76 (+0.49), CAMT: 2.99 (+0.14), AAPL: 114.62 (+1.07), NVMI: 12.13 (+0.06)

Fitbit Wins Latest Round of Legal Fight Against Jawbone
Zacks Equity Research - Zacks Investment Research - Thu Aug 25, 7:36AM CDT
Fitbit Inc. (FIT) has received a favorable ruling in the latest round of the Jawbone trade secret case.
FIT: 16.76 (+0.49), CAMT: 2.99 (+0.14), BCOR: 11.02 (+0.11), NVMI: 12.13 (+0.06)

Fitbit (FIT) Q2 Earnings Top; Stock Falls 3% on Weak Outlook
Zacks Equity Research - Zacks Investment Research - Wed Aug 03, 11:02AM CDT
Fitbit, Inc. (FIT) reported second-quarter 2016 adjusted earnings of 7 cents per share, which surpassed the Zacks Consensus Estimate of 4 cents.
FIT: 16.76 (+0.49), AMKR: 9.39 (+0.17), CAMT: 2.99 (+0.14), MEET: 5.96 (+0.14)

Camtek Launches Innovative Inspection Method for Fan-out Applications Using Computer-aided Design Data as Reference
PR Newswire - Wed Jun 22, 6:00AM CDT
Camtek Ltd. (NASDAQ: CAMT; TASE: CAMT), today announced the launch of an innovative inspection method for Fan-Out Wafer Level Packaging (FOWLP). This new inspection method compares the image acquisition of the dies on the reconstructed wafer with the computer-aided design (CAD) data used in fabricating the wafer.
CAMT: 2.99 (+0.14)

Camtek to Present at the 17th Annual B. Riley & Co. Annual Investor Conference
PR Newswire - Mon May 23, 6:00AM CDT
Camtek Ltd. (Nasdaq: CAMT ; TASE: CAMT) announced that it will participate at the 17th Annual B. Riley & Co. Annual Investor Conference to be held between May 25 - 26, 2016 at the Loews Hollywood Hotel in Los Angeles, California.
CAMT: 2.99 (+0.14)

Camtek posts 1Q profit
Automated Insights - Thu May 05, 6:59AM CDT
MIGDAL HAEMEK, Israel (AP) _ Camtek Ltd. (CAMT) on Thursday reported first-quarter profit of $24,000.
CAMT: 2.99 (+0.14)

Camtek Announces First Quarter 2016 Results
PR Newswire - Thu May 05, 6:10AM CDT
Camtek Ltd. (NASDAQ: CAMT; TASE: CAMT), today announced its financial results for the quarter ended March 31, 2016.
CAMT: 2.99 (+0.14)

Camtek Schedules First Quarter 2016 Results Release and Conference Call for Thursday, May 5, 2016
PR Newswire - Tue Apr 26, 8:00AM CDT
Camtek Ltd. (Nasdaq: CAMT; TASE: CAMT) announced that it would be releasing its financial results for the first quarter of 2016 on Thursday, May 5, 2016.
CAMT: 2.99 (+0.14)

Camtek Announces Final Ruling in Patent Litigation Case
PR Newswire - Wed Feb 03, 2:53PM CST
Camtek Ltd. (Nasdaq: CAMT; TASE: CAMT) reported today that the United States Court of Appeals for the Federal Circuit entered its judgment regarding Camtek's appeal in the patent infringement case of Rudolph Technologies Inc. against Camtek regarding the Falcon systems. The Court of Appeals reaffirmed the Minnesota Court's Ruling in Rudolph Technologies' favor, and reinstated the damages originally awarded which total, including interest, approximately $14.6 million, as well as the injunction in connection with sales of the Falcon systems in the United States until the expiration of plaintiff's patent. Camtek shall record a reserve for the awarded amount in its financial statements for year 2015.
CAMT: 2.99 (+0.14), RTEC: 17.87 (+0.24)

Release and Conference Call for Thursday, February 11, 2016
M2 - Thu Jan 28, 8:46AM CST
Camtek Ltd. (Nasdaq: CAMT; TASE: CAMT) announced that it would be releasing its financial results for the fourth quarter and full year of 2015 on Thursday, February 11, 2016.
CAMT: 2.99 (+0.14)

Camtek Schedules Fourth Quarter and Full Year 2015 Results Release and Conference Call for Thursday, February 11, 2016
PR Newswire - Thu Jan 28, 4:38AM CST
Camtek Ltd. (Nasdaq: CAMT; TASE: CAMT) announced that it would be releasing its financial results for the fourth quarter and full year of 2015 on Thursday, February 11, 2016.
CAMT: 2.99 (+0.14)

Camtek receives over USD 3m multiple systems repeat orders
M2 - Mon Jan 11, 10:10AM CST
Camtek Ltd. (NASDAQ: CAMT; TASE: CAMT) has received repeat orders for multiple systems totaling over USD 3 million from a global, world leading OSAT (Outsourced Semiconductors Assembly and Test), the company said.
CAMT: 2.99 (+0.14)

CAMTEK RECEIVES OVER $3 MILLION MULTIPLE SYSTEMS REPEAT ORDERS FROM A GLOBAL OSAT
M2 - Thu Jan 07, 11:17AM CST
Camtek Ltd. (NASDAQ: CAMT; TASE: CAMT), today announced the receipt of repeat orders for multiple systems totaling over $3 million from a global, world leading OSAT (Outsourced Semiconductors Assembly and Test). The systems will be installed during the first quarter of 2016. The systems will be used for inspection and metrology of advanced packaging applications.
CAMT: 2.99 (+0.14)

Camtek Receives Over $3 Million Multiple Systems Repeat Orders From a Global OSAT
PR Newswire - Thu Jan 07, 6:15AM CST
Camtek Ltd. (NASDAQ: CAMT; TASE: CAMT), today announced the receipt of repeat orders for multiple systems totaling over $3 million from a global, world leading OSAT (Outsourced Semiconductors Assembly and Test). The systems will be installed during the first quarter of 2016. The systems will be used for 3D inspection and metrology of advanced packaging applications.
CAMT: 2.99 (+0.14)

Camtek to Present at the 18th Annual Needham Growth Conference
PR Newswire - Mon Jan 04, 10:45AM CST
Camtek Ltd. (Nasdaq: CAMT ; TASE: CAMT) announced that it will be presenting at the 18th Annual Needham Growth Conference to be held between January 12 - 14, 2016 at the Lotte New York Palace Hotel in New York.
CAMT: 2.99 (+0.14)

Camtek's Gryphon SL Wins the Annual Global Technology Award 'Environmentally-Friendly Products' Category at Productronica
PR Newswire - Thu Dec 03, 7:20AM CST
Camtek Ltd. (NASDAQ and TASE: CAMT), today announced that Gryphon SL, its one-stop-shop solder mask and legend deposition system, has won the Global Technology Award in the environmentally-friendly product category.
CAMT: 2.99 (+0.14)

Camtek to Participate in the Fourth Annual Midtown Cap Investor Summit 2015
PR Newswire - Tue Dec 01, 8:24AM CST
Camtek Ltd. (NASDAQ and TASE: CAMT), today announced that Moshe Eisenberg, CFO is scheduled to participate in the 4th Annual Midtown CAP Investor Summit 2015, being held Thursday, December 10, 2015 at the Le Parker Méridien Hotel, New York, NY.
CAMT: 2.99 (+0.14)

Camtek Receives Orders of Over $4 Million for Multiple Systems from a Top Semiconductor Foundry
PR Newswire - Mon Nov 23, 6:10AM CST
Camtek Ltd. (NASDAQ and TASE: CAMT), today announced that one of the world's leading semiconductor foundries placed multiple orders totaling over $4 million for inspection and metrology systems to be installed in the fourth quarter of 2015. Further additional orders are expected in December for delivery in the first quarter of 2016.
CAMT: 2.99 (+0.14)

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

LaserAway Expands to 244 Clinics Over 20 Years

A Milestone in Aesthetic Dermatology Twenty years, folks. That's a long haul for most businesses, let alone one in the fickle field of aesthetic dermatology. LaserAway, the juggernaut in this arena, has just opened its 244th clinic at 6300 Kingery Hwy in Willowbrook, IL. Nothing to be sneezed at. Imagine running a business, let alone one that's been amping up aesthetic...

Windward Bio Surges 68% in Nasdaq Debut

By Ryan Hughes Updated Nov 13, 2026 Category News Views 206

Windward Bio's Impressive Nasdaq Debut Well, how's that for a debut? Windward Bio, this buzzing clinical-stage biotechnology firm, hit Nasdaq like a storm on November 13, 2026. They priced their IPO at $17.00 per share, but by market close, the stock sat comfortably at $28.50. That's a hearty 68% jump on day one, putting their market value at a sweet $1.69 billion. Behind...

WeFetch AI: A New Era in Barcode Precision

By Logan Wright Updated Nov 13, 2026 Category News Views 201

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Novo's CagriSema Trial Shows Promising Obesity Results

Novo's Latest Weight Loss Gamble Well, look what we have here. Novo Nordisk is shaking up the obesity treatment scene with some bold numbers from their REDEFINE 9 trial. The investigational CagriSema combo of amylin analog and GLP-1 receptor agonist has churned out an eyeball-popping near 21% weight loss. For context, we're staring down the barrel of numbers far meatier...

Retirement Dreams Dashed: 61% Withdraw Early

By Olivia Taylor Updated Nov 14, 2026 Category News Views 183

Retirement Caught in the Crosshairs Just when you think the path to retirement might clear up, life slaps down older workers with economic reality. A recent LiveCareer survey underscores this financial mess, revealing that 61% of those 50 and older are raiding their own retirement funds to make ends meet. It's enough to make one's head spin. Inflation: The Unwanted Guest...

EZaccessMD Data Breach: Class Action Lawsuit Looms

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

BETR's Slide: Investors Face Big Losses, Leadership Shift

BETR Investors Left in the Lurch It's a real trainwreck, folks. Better Home & Finance Holding Company, trading under NASDAQ:BETR, is in the spotlight for all the wrong reasons. The company expanded the class period for its investor lawsuit to include even more dates between March and August 2026, reflecting a torturous ride for shareholders. Their stock cratered by a...

Beko Pushes for Policy Synergy Amidst Carbon Shakeup

When big names like Beko step up on the global stage, you pay attention. During the COP31 panels in Antalya, Türkiye, the company's brass made one thing clear: we need harmony in how climate, trade, and finance policies come together. The stakes? The very strength of industrial competitiveness as new carbon rules turn the heat up on manufacturing practices. The Call for...

Manhattan Associates Faces Investigation by KSF Law Firm

KSF Digs Into Manhattan Associates' Claims In the swirl of the financial world, you rarely see an investigation that doesn’t raise a few eyebrows. This time, it's Manhattan Associates, Inc. (NasdaqGS: MANH) squarely in the crosshairs of Kahn Swick & Foti, LLC (KSF), a pivotal player in securities litigation. You’ve got to wonder what dirt might be uncovered here,...